1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bronchopulmonary Dysplasia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, JM; Kanda, Y; Maki, N; Miyauchi, K; Suzuki, T; Wada, Y | 1 |
| Blank, ML; Gaylord, MS; Lorch, V; Smith, ZL; Snyder, F | 1 |
| Brigham, KL | 1 |
| Eyzaguirre, M; Henson, PM; Murphy, RC; Stenmark, KR; Westcott, JY | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
[Analysis of platelet-activating factor and its effect on the lung].
Topics: Animals; Asthma; Biological Assay; Bronchoconstriction; Bronchopulmonary Dysplasia; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Lung; Mass Spectrometry; Platelet Activating Factor; Pregnancy; Pulmonary Surfactants; Rabbits; Radioimmunoassay | 1993 |
Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Biomarkers; Bronchopulmonary Dysplasia; Humans; Infant, Low Birth Weight; Infant, Newborn; Male; Phospholipases A; Platelet Activating Factor; Prognosis | 1996 |
Conference summary: lipid mediators in the pulmonary circulation.
Topics: Animals; Bronchopulmonary Dysplasia; Eicosanoic Acids; Humans; Infant, Newborn; Lung; Lung Diseases, Obstructive; Neutrophils; Platelet Activating Factor; Pulmonary Circulation; Superoxides | 1987 |
Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Eicosanoic Acids; Humans; Infant, Newborn; Lung; Platelet Activating Factor; Therapeutic Irrigation | 1987 |